Eleven of the 11 datasets from Oncomine, which contain gene chip profiles classified as normal or breast carcinoma tissues, showed that FOXC1 mRNA levels were much higher in ERα‐negative breast cancers than that in ERα‐positive breast cancers (Fig. 2 and S2). This evidence concerns the gene ESR1 and breast cancer.